» Articles » PMID: 12169477

Cranial MR Findings in Chronic Toluene Abuse by Inhalation

Overview
Specialty Neurology
Date 2002 Aug 10
PMID 12169477
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Chronic abuse of toluene by inhalation causes variable white matter changes and thalamic hypointensity on T2-weighted MR images. The purpose of our study was to assess cranial MR findings in a large series of patients who chronically abuse toluene-containing solvents to investigate the factors causing the qualitative variability of white matter changes and thalamic hypointensity.

Methods: We studied the neurologic signs, symptoms, and cranial MR findings in 41 patients who chronically abused thinner, a toluene-containing solvent. We classified white matter changes as diffuse or restricted. We tested the associations of the development of white matter lesions and thalamic hypointensity with patient age at onset of abuse and duration of abuse.

Results: MR images revealed white matter lesions in 46% of the patients, atrophic dilatation of ventricles and sulci in 27%, and thalamic hypointensity in 20%. White matter changes were restricted in 53% and diffuse in 47%. The development of white matter changes and thalamic hypointensity were significantly associated with duration of abuse longer than 4 years (P <.05 and P <.01, respectively).

Conclusion: White matter changes seem to start in the deep periventricular white matter, and they spread into peripheral white matter, causing the loss of gray matter-white matter differentiation with continued toluene abuse. The deposition of iron due to demyelination and axonal loss is the most probable mechanism for the thalamic hypointensity found in solvent abusers.

Citing Articles

Acute organic solvent toxic encephalopathy: A case report and literature review.

Wang Y, Du P Biomed Rep. 2024; 21(5):163.

PMID: 39268402 PMC: 11391175. DOI: 10.3892/br.2024.1851.


Occupational and domestic exposure associations with cerebral small vessel disease and vascular dementia: A systematic review and meta-analysis.

Clancy U, Cheng Y, Brara A, Doubal F, Wardlaw J Alzheimers Dement. 2024; 20(4):3021-3033.

PMID: 38270898 PMC: 11032565. DOI: 10.1002/alz.13647.


Abuse-like toluene exposure during early adolescence alters subsequent ethanol and cocaine behavioral effects and brain monoamines in male mice.

Davidson C, Hannigan J, Perrine S, Bowen S Neurotoxicol Teratol. 2024; 101:107317.

PMID: 38199311 PMC: 11629394. DOI: 10.1016/j.ntt.2023.107317.


Intranasal Methylprednisolone Ameliorates Neuroinflammation Induced by Chronic Toluene Exposure.

Giraldo-Velasquez M, Perez-Osorio I, Espinosa-Ceron A, Barcena B, Calderon-Gallegos A, Fragoso G Pharmaceutics. 2022; 14(6).

PMID: 35745768 PMC: 9230943. DOI: 10.3390/pharmaceutics14061195.


Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired Disorders.

Fearon C, Rawal S, Olszewska D, Alcaide-Leon P, Kern D, Sharma S Mov Disord Clin Pract. 2022; 9(3):311-325.

PMID: 35402651 PMC: 8974867. DOI: 10.1002/mdc3.13415.


References
1.
Knox J, Nelson J . Permanent encephalopathy from toluene inhalation. N Engl J Med. 1966; 275(26):1494-6. DOI: 10.1056/NEJM196612292752608. View

2.
Boor J, Hurtig H . Persistent cerebellar ataxia after exposure to toluene. Ann Neurol. 1977; 2(5):440-2. DOI: 10.1002/ana.410020518. View

3.
Yamanouchi N, Okada S, Kodama K, Hirai S, Sekine H, Murakami A . White matter changes caused by chronic solvent abuse. AJNR Am J Neuroradiol. 1995; 16(8):1643-9. PMC: 8337781. View

4.
Woolfson R . Psychological correlates of solvent abuse. Br J Med Psychol. 1982; 55(Pt 1):63-6. DOI: 10.1111/j.2044-8341.1982.tb01483.x. View

5.
Ron M . Volatile substance abuse: a review of possible long-term neurological, intellectual and psychiatric sequelae. Br J Psychiatry. 1986; 148:235-46. DOI: 10.1192/bjp.148.3.235. View